GENEPLAZA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GENEPLAZA
Largest movements
- Receivables within one year +€6,265
up €6,265 (+5,707%), from €110 to €6,375
of which Trade receivables: +€6,050
- Cash +€1,530
up €1,530 (+28.3%), from €5,400 to €6,930
mainly Net result for the year (+€4,743) and Trade debts (+€4,053)
- Profit (loss) carried forward +€4,743
up €4,743 (+15.2%), from -€31,249 to -€26,506
- Trade debts +€4,053
up €4,053 (+79.7%), from €5,084 to €9,137
- Other debts -€1,873
down €1,873 (-15.0%), from €12,483 to €10,609
- Tax, wage and social debts +€801
up €801 (+797%), from €100 to €902
- Accrued charges and deferred income +€413
new in 2025: €413
- Gross operating margin +€10,174
up €10,174, from -€4,960 to €5,213
- Financial charges -€787
down €787 (-90.2%), from €873 to €85
- Other operating charges -€455
down €455 (-53.2%), from €855 to €400
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €5,510 | €13,305 | +€7,796 | +141% |
| Current assets | 29/58 | €5,510 | €13,305 | +€7,796 | +141% |
| Amounts receivable within one year | 40/41 | €110 | €6,375 | +€6,265 | +5,707% |
| Trade receivables | 40 | - | €6,050 | +€6,050 | |
| Other amounts receivable | 41 | €110 | €325 | +€215 | +196% |
| Cash at bank and in hand | 54/58 | €5,400 | €6,930 | +€1,530 | +28.3% |
| Total equity and liabilities | 10/49 | €5,510 | €13,305 | +€7,796 | +141% |
| Equity | 10/15 | -€12,649 | -€7,906 | +€4,743 | +37.5% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€31,249 | -€26,506 | +€4,743 | +15.2% |
| Amounts payable | 17/49 | €18,159 | €21,211 | +€3,053 | +16.8% |
| Amounts payable within one year | 42/48 | €18,159 | €20,799 | +€2,640 | +14.5% |
| Financial debts | 43 | €491 | €150 | -€341 | -69.4% |
| Credit institutions | 430/8 | €491 | €150 | -€341 | -69.4% |
| Trade debts | 44 | €5,084 | €9,137 | +€4,053 | +79.7% |
| Suppliers | 440/4 | €5,084 | €9,137 | +€4,053 | +79.7% |
| Taxes, remuneration and social security | 45 | €100 | €902 | +€801 | +797% |
| Taxes | 450/3 | €100 | €902 | +€801 | +797% |
| Other amounts payable | 47/48 | €12,483 | €10,609 | -€1,873 | -15.0% |
| Accrued charges and deferred income | 492/3 | - | €413 | +€413 | |
| Other operating charges | 640/8 | €855 | €400 | -€455 | -53.2% |
| Gross operating margin | 9900 | -€4,960 | €5,213 | +€10,174 | |
| Operating profit (loss) | 9901 | -€5,815 | €4,813 | +€10,629 | |
| Financial income | 75/76B | €3 | €15 | +€12 | +410% |
| Recurring financial income | 75 | €3 | €15 | +€12 | +410% |
| Financial charges | 65/66B | €873 | €85 | -€787 | -90.2% |
| Recurring financial charges | 65 | €873 | €85 | -€787 | -90.2% |
| Profit (loss) for the period before taxes | 9903 | -€6,685 | €4,743 | +€11,428 | |
| Profit (loss) for the period | 9904 | -€6,685 | €4,743 | +€11,428 | |
| Profit (loss) for the period to be appropriated | 9905 | -€6,685 | €4,743 | +€11,428 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.